(IN BRIEF) I am excited to share that XSpline SPA and Ordensklinikum Linz Elisabethinen Hospital have enrolled the first patient…
(IN BRIEF) Dr. Georgios Kollias, the principal investigator for the clinical trial in Austria, expressed great satisfaction with the XSpline…
XSpline Cloud: First-in-class cloud platform for personalized cardiac resynchronization therapy evaluated in International Clinical Trial; first procedure performed at the…
Unique Next-Generation Device Evaluated in International Clinical Trial; First Procedure Performed at the University of Texas Health Science Center at…
Turku, 29-5-2013 — /europawire.eu/ — Biotie Therapies today announced the start of a Phase 2 clinical study evaluating nepicastat (SYN117) in…